
|Articles|July 25, 2018
Novartis Partners with SHYFT
Advertisement
SHYFT Analytics announced that Novartis selected its Intelligent Platform for Life Sciences to support the commercialization of therapies in Europe.
Novartis will use the following SHYFT solutions:
- STRATA Data Platform to aggregate and manage a growing number of third party and proprietary commercial data sources
- LUMEN Insights Platform to deliver intuitively-designed analytics to drive the “next-best-actions” for commercial teams
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising, Alleging Misleading Dosing Comparisons
3
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
4
Developing Better Drugs, Not Just More Drugs: Q&A with David Hung
5




